par Jacobs, Bart;De Roock, Wendy;Piessevaux, Hubert;Van Oirbeek, Robin;Biesmans, Bart;De Schutter, Jef;Fieuws, Steffen;Vandesompele, Jo;Peeters, Marc;Van Laethem, Jean-Luc
;Humblet, Yves;Pénault-Llorca, Frederique;De Hertogh, Gert;Laurent, Pierre
;Van Cutsem, Eric;Tejpar, Sabine
Référence Journal of clinical oncology, 27, 30, page (5068-5074)
Publication Publié, 2009-10


Référence Journal of clinical oncology, 27, 30, page (5068-5074)
Publication Publié, 2009-10
Article révisé par les pairs
Titre: |
|
Auteur: | Jacobs, Bart; De Roock, Wendy; Piessevaux, Hubert; Van Oirbeek, Robin; Biesmans, Bart; De Schutter, Jef; Fieuws, Steffen; Vandesompele, Jo; Peeters, Marc; Van Laethem, Jean-Luc; Humblet, Yves; Pénault-Llorca, Frederique; De Hertogh, Gert; Laurent, Pierre; Van Cutsem, Eric; Tejpar, Sabine |
Informations sur la publication: | Journal of clinical oncology, 27, 30, page (5068-5074) |
Statut de publication: | Publié, 2009-10 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Antibodies, Monoclonal -- therapeutic use |
Antineoplastic Agents -- therapeutic use | |
Camptothecin -- analogs & derivatives -- therapeutic use | |
Cohort Studies | |
Colorectal Neoplasms -- drug therapy -- genetics -- mortality -- secondary | |
Epidermal Growth Factor -- genetics | |
Gene Expression | |
Glycoproteins -- biosynthesis -- genetics | |
Humans | |
Intercellular Signaling Peptides and Proteins -- biosynthesis -- genetics | |
Ligands | |
Prognosis | |
Proto-Oncogene Proteins -- genetics | |
RNA, Messenger -- genetics | |
Receptor, Epidermal Growth Factor -- antagonists & inhibitors -- genetics | |
Survival Analysis | |
ras Proteins -- genetics | |
Note générale: | Journal Article |
Research Support, Non-U.S. Gov't | |
Langue: | Anglais |
Identificateurs: | urn:issn:0732-183X |
info:doi/10.1200/JCO.2008.21.3744 | |
info:pii/JCO.2008.21.3744 | |
info:pmid/19738126 |